The latest announcement is out from Elanco Animal Health (ELAN).
Elanco Animal Health Incorporated implemented significant board and governance changes at their 2024 Annual Meeting, which included the appointment of Kathy Turner to the Board for a term expiring in 2025, and the re-allocation of Lawrence Kurzius to the class expiring in 2026. Shareholders voted in favor of amendments to declassify the Board, adopt a majority vote standard for director elections, and enhance shareholder rights to amend bylaws and call special meetings. Additionally, Ernst & Young LLP was ratified as the independent auditor, and executive compensation was approved.
For detailed information about ELAN stock, go to TipRanks’ Stock Analysis page.
